Brief: Innate Pharma Says Jonathan Dickinson To Be Appointed CEO And Board Member
16/04/2025 06:07
April 16 (Reuters) - Innate Pharma SA IPH.PA: INNATE PHARMA PROPOSES TO ITS SHAREHOLDERS TO TRANSFORM ITS CORPORATE GOVERNANCE STRUCTURE INTO A BOARD OF DIRECTORS AND TO CHANGE ITS COMPOSITION INNATE PHARMA SA - PROPOSES GOVERNANCE CHANGE TO CEO/BOARD STRUCTURE INNATE PHARMA SA - JONATHAN DICKINSON TO BE APPOINTED CEO AND BOARD MEMBER INNATE PHARMA SA - CO-FOUNDER HERVÉ BRAILLY NOT SEEKING RE-APPOINTMENT TO BOARD Source text: ID:nBwcgBN7Ka Further company coverage: IPH.PA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innate Pharma SA
See all newsBrief: Innate Pharma Announces Completion Of Enrollment In Phase 1 Dose Escalation Study Of Iph4502
France's Innate Pharma posts lower 2025 revenue as key contracts decline
Brief: Innate Pharma FY Operating Expenses EUR -63.013 Million
Brief: Innate Pharma Sa Says Sanofi to invest up to 15 million Euros In Innate Pharma
Brief: Innate Pharma Says Jonathan Dickinson To Be Appointed CEO And Board Member